The NIH Helping to End Addiction Long-term (HEAL) Initiative funding opportunity announcements (FOAs) have just been released. Webinars to introduce the audience to a selection of these FOAs, all seeking to develop medical devices to treat pain, are scheduled on (all times are eastern):
Funding Opportunity Announcements
- HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
RFA-EB-18-003 - HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
RFA-NS-19-016 - HEAL Initiative Translational Devices to Treat Pain (U44 Clinical Trial Optional)
RFA-NS-19-017 - HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
RFA-NS-19-018 - HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional)
RFA-RM-19-001
For more information and to register for the webinars see https://www.nibib.nih.gov/devices_for_pain. Additional information about the HEAL Initiative can be found at:
- NIH Director’s Statement regarding new HEAL FOAs
- Updated NIH HEAL Research Plan